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Abstract
Considering that 80 genomes have been sequenced, providing us with the static information of the
genome, it is still a long way to reveal the relationship between complex genotypes and phenotypes.
The transcriptional regulation process is one of the obstacles that need to be understood to bridge
our current information gap. It describes the first step from the genomic sequence information to
RNA templates used for protein production or as direct functional units, like non-coding RNAs
(e.g. micro RNAs). This introduction aims to highlight the key aspects of the transcriptional process
from our current understanding.
Introduction
The transcriptome as the pool of all transcribed elements
in a given cell varies depending upon its context. Looking
at gene expression in mammalian organisms several spa-
tial and temporal restrictions occur. RNA can be trans-
ported as a ribonucleoprotein (RNP) particle to specific
cellular locations, e.g. tau mRNA in neurons, leading to a
location gradient of RNA within a single cell. Many genes
show transient expression at particular developmental
stages (e.g. globin genes), at specific times in the cell cycle
(e.g. histone genes during S phase) or in response to envi-
ronmental signals. This implies that the expression of a
gene is highly coordinated and influenced by a broad
panel of external and internal cellular factors (Figure 1).
This review aims to highlight the key aspects and for
advanced reading see additional file 1.
RNA factory
In eukaryotes RNA synthesis is catalyzed by three different
RNA polymerases depending on the type of RNA pro-
duced. RNA polymerase II promotes the synthesis of the
pre-mRNA coding for proteins. It consists of twelve subu-
nits, where the largest subunit contains an essential car-
boxyl terminal domain that is phosphorylated during
initiation. The majority of RNA polymerase II promoters
are characterized by a TATA box approximately 25 to 35
base pairs upstream of the transcriptional start site (TSS).
Frequently genes transcribed at a low rate coding for
housekeeping genes are marked by a GC-rich stretch of
20–50 nucleotides within the first 100 bp upstream of the
TSS and are in part recognized by the transcription factor
SP1. The transcriptional initiation by RNA polymerase II
at almost all promoters requires a set of several general
multi-protein transcription factor complexes (TFIID,
TFIIA; TFIIF; TFIIE; TFIIH). TFIID contains the TATA box-
binding protein, and TFIIH the helicase to separate DNA
strands and kinase to phosphorylate the carboxylterminal
domain of the RNA polymerase II.
Although transcription is the first and probably most
highly regulated step in expression, it is usually only the
beginning of a series of events required to produce a func-
tional RNA. Primary transcripts of eukaryotic mRNAs
undergo extensive modifications, such as 5'capping, splic-
ing and 3'poly-A strand addition. These RNA processing
steps are tightly coupled to the transcriptional elongation
and the promoting factors are mainly bound to the phos-
phorylated tail of the RNA polymerase II. As soon as RNA
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the 5'end of the new RNA molecule is modified by addi-
tion of a "cap" that consists of a modified guanine nucle-
otide. This landmark helps the cell to distinguish mRNAs
from other types of RNA molecules present within the
cells and is bound by the cap-binding protein complex
(CBC). The CBC promotes proper processing and finally
the export of RNA.
RNA splicing is the critically important step in which the
different portions of a eukaryotic protein coding sequence
are joined together by removing transcribed intron
sequences. In human transcripts around 60% of genes are
spliced in a variety of ways to produce a set of different
mRNAs, thereby allowing a corresponding set of different
proteins to be produced from the same gene, which can
also be cell type specific, e.g. α-tropomyosin in striated
muscle, smooth muscle, fibroblast and brain. Splicing is
performed largely by RNA molecules instead of proteins
such that specific RNA molecules (small nuclear RNAs,
snRNAs) recognize intron-exon borders and participate in
the chemistry of splicing. Each snRNA is complexed with
at least seven protein subunits to form a snRNP (small
nuclear ribonucleoprotein) that forms the core of the spli-
RNA abundance in a cellFigure 1
RNA abundance in a cell. Shown is an overview of factors regulating RNA abundance in a cell.Page 2 of 6
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mRNA is emerging from a transcribing RNA polymerase
II. Several components of the spliceosome are carried on
the phosphorylated tails of RNA polymerase. Their trans-
fer directly from the polymerase to the nascent pre-mRNA
helps the cell to keep track of introns and exons. Further-
more, the exon sizes are much more uniform than intron
sizes, averaging about 150 nucleotide pairs across a wide
variety of eukaryotic organism. A group of spliceosome
components, called SR proteins, assemble on exon
sequences and mark each 3' and 5' splice sites. If splice-
site selection were determined solely by the snRNPs acting
on a preformed, protein-free RNA molecule, mistakes
such as exon skipping and the use of cryptic splice sites
would be very common.
Consensus nucleotide sequences of the RNA at the 3'end
encode the cleavage and polyadenylation signal for the
cleavage stimulation factor (CstF) and cleavage/polyade-
nylation specificity factor (CPSF), which travel to the
3'end processing sequence at the RNA polymerase II tail.
After the 3'end is cleaved, the RNA polymerase II contin-
ues to transcribe, in some cases as many as several hun-
dred nucleotides beyond the DNA that contains the 3'
cleavage-site information. However, the polymerase soon
releases its grip on the template and transcription termi-
nates. The piece of RNA downstream of the cleavage site is
then degraded in the cell nucleus. Potential triggers that
stop polymerase II processivity after RNA cleavage are a
conformation change of the polymerase due to the trans-
fer of the 3'end processing factors from the polymerase
tail or feedback signaling due to the lack of the cap struc-
ture on the 5'end of the RNA that emerges from the
polymerase.
RNA turnover
In eukaryotes the transcriptional process is physically sep-
arated from the translational process (nucleus, cyto-
plasm) and the mRNA transport into the cytosol as well as
the mRNA stability are highly controlled. Usually an
mRNA must be marked by the appropriate set of proteins
to be transported, like the cap-binding complex being
bound and others like specific snRNP proteins being
absent. Other proteins, placed on the RNA during splic-
ing, mark exon-exon boundaries and signify complete
splicing events. In eukaryotic cells, mRNAs are quite stable
and some, like the β-globin mRNA, have half-lives of
more than 10 hours, however, many have half-lives of 30
minutes or less. Unstable mRNAs often code for regula-
tory proteins, such as growth factors and gene regulatory
proteins, whose production rates have to be changed rap-
idly. In contrast, the vast majority of mRNAs in a bacterial
cell are very unstable, having a half-life of about 3 min-
utes, and this high turnover enables the quick adaptation
to environmental changes. The nuclear decay of RNA
involves both 3' to 5'and 5' to 3' exonucleases, where the
first is the best studied mechanism and forms a complex
termed the exosome. A significant RNA turnover occurs
co-transcriptionally, probably at a number of stages dur-
ing initiation and elongation by RNA polymerase II.
Another aspect of RNA surveillance plays the handling of
double-stranded RNAs, produced by inadvertent bidirec-
tional transcription. Such RNAs are subjected to extensive
adenosine-to-inosine editing by enzymes called ADARs
(adenosine deaminase acting on RNA), which destroy
their double-helical character and ability to enter the RNA
interference pathway. Short interfering RNAs (siRNAs)
and microRNAs (miRNAs) are components of the RNA
based mechanism of gene regulation at the transcriptional
and post-transcriptional level respectively, which leads to
cleavage of suspected target RNAs. Once in the cytoplasm,
mRNAs are further subjected to translation-dependent
surveillance. Here a process called nonsense-mediated
mRNA decay (NMD) provides a mean to degrade abnor-
mal mRNAs that encode potentially deleterious truncated
proteins. Additionally, an estimated one-third of naturally
occurring, alternatively spliced mRNAs are also targeted
for NMD, potentially providing an additional mechanism
to achieve proper levels of gene expression.
Chromatin remodeling
DNA is packaged into chromatin thereby constraining the
size of the molecule that is approximately 2 meters of
DNA per human cell. Chromatin represents a repeating
unit of histones and DNA that form the nucleosome.
Highly condensed chromatin (heterochromatin) is tran-
scriptionally silent. Simplistically, there are three major
levels of chromatin organization: nucleosomes as "beads
on a string", 30 nm chromatin fiber consisting of packed
nucleosome arrays and highly condensed metaphase
chromosomes. In general, 146 bp of DNA are wrapped
around a nucleosome core consisting of an assembled his-
tone H3-H4 tetramer and two H2A-H2B dimers. The
interaction of DNA with the positively charged histones is
made through the negatively charged DNA backbone.
Histones are highly conserved, and H3 and H4 are even
the most highly conserved proteins in nature. Approxi-
mately 60 million molecules of each histone are present
in a human cell. The majority of histones in proliferating
cells are synthesized during the S phase of the cell cycle,
when they are rapidly deposited onto newly replicated
DNA. Disruption of this replication-dependent nucleo-
some assembly in humans triggers spontaneous DNA
damage, S phase arrest and chromosome rearrangements,
where the latter is a prominent feature of many human
cancers. However, excess histone accumulation is harmful
to cells because they bind non-specifically to DNA, thus
interfering with many processes. Mechanisms of how his-
tone degradation and abundance are controlled are cur-
rently a field of major interest.Page 3 of 6
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transcriptional machinery with the RNA polymerases, the
DNA needs to be unwrapped from the histone core. Sev-
eral methods of chromatin remodeling have been pro-
posed, such as deposition of histones by chaperones,
assembly and reassembly of nucleosomes by ATP-depend-
ent factors and DNA translocation enzymes. Further spe-
cific patterns of modification of histone tails attract or
repel regulatory proteins of the chromatin remodeling
complex. Histone modifications can influence one
another and thus, not just the level of modification but
also the pattern may dictate biological outcome. The main
modifications are acetylation and methylation, followed
by phosphorylation. A panel of histone acetyl transferases
(HAT), histone deacetylases (HDAC) and histone methy-
lases (HMT) has been identified that intricate gene regula-
tion. Histone acetylation is so far the best studied
modification, here an acetyl group is covalently bound to
basic amino acids in histones and neutralizes the positive
charge of histones. Therefore, ionic interaction between
the histone core and DNA is decreased leading to a
decrease in chromatin condensation. Different modifica-
tion types, like acetylation of histone 4 or histone 3 could
be associated with active transcription of the respective
gene. Specific patterns of histone modifications attract or
repel regulatory proteins, e.g. bromodomain proteins
bind to acetylated lysine and chromodomain proteins
bind to methylated lysine residues of the histone tail. Bro-
modomain containing proteins are components of TAF
complexes binding to the TATA-box binding protein
(TBP). Transcriptional activators can recruit histone acety-
lases to initiate transcription and repressors can recruit
deacetylases to prevent the access of the transcriptional
machinery to the DNA by a higher condensation of the
DNA template.
Although non-histone proteins and histone modifica-
tions are key features of specialized chromatin domains
such as heterochromatin, these domains are also charac-
terized by the incorporation of specific histone variants.
The majority of histone variants documented to date cor-
respond to two types of histones, H2A and H3. Among
H2A variants, H2A.X is one of the best studied ones, given
its specific phosphorylation during DNA damage
response. A major H3 variant is CENP-A (centromere pro-
tein A), an evolutionary conserved replacement variant
that is specific for centromeric chromatin and is essential
for centromere function, like chromosomal alignment
and segregation.
DNA methylation
Once differential expression patterns have been set up,
epigenetic mechanisms can ensure that differential
expression patterns are stably inherited when cells divide.
DNA methylation is thought to play a major role in this
respect permitting the stable transmission from a diploid
cell to daughter cells of chromatin states that repress gene
expression. DNA methylation is a covalent modification
of the DNA and does not alter the base pairing. It occurs
in almost all living organisms, from bacteria to plant and
fungi, from invertebrates to vertebrates. Its abundance
and role differs among these genomes. The pattern of
DNA methylation changes dramatically during mamma-
lian development, such that primordial germ cells consist
of mainly unmethylated DNA, which becomes methyl-
ated during the development to germ cells. Sperm cells
show a higher degree of methylation than egg cells and
after fertilization a demethylation process during early
embryonic development until the blastocyst stage takes
place. During pregastrulation the DNA of somatic cell lin-
eages and of trophoblast lineages gain a de novo methyla-
tion, whereas the primordial germ cells stay
unmethylated. e.g. methylation of globin genes in human
embryonic blood cells correlates inversely with the activ-
ity of the globin genes.
In eukaryotes DNA methylation is mainly restricted to
cytosine residues and occurs predominantly at the dinu-
cleotide CpG. Only about 3% of the cytosines in human
DNA are methylated and most can be found in CpG dinu-
cleotides, where 80% of cytosines are methylated. CpG
islands, short stretches of DNA that are often less then 1
kb long, contain frequently unmethylated CpG dinucle-
otides in vertebrates. During the course of evolution,
more than 3 of 4 CpGs have been lost, leading to an une-
ven distribution. This marked overall deficiency of CpG
sequences and their clustering into CpG islands in verte-
brates could potentially be explained by two findings.
Deamination of 5-methylcytosine results in thymidine,
which forms mismatches with guanine that are ineffi-
ciently recognized by the DNA repair system. However,
deamination of cytosine results in uracil that is efficiently
recognized by the DNA repair system, exercised and
replaced. CG sequences placed in regulatory sequences of
genes that are transcribed in germ cells are unmethylated
and therefore tend to be retained in evolution. Approxi-
mately 30,000 CpG islands are found in mammalian
genomes, mostly located at promoters of housekeeping
genes and some tissue-specific genes. Methylation of
CpGs near tumor suppressor genes like p53 or p16, are
often related to silencing of these genes in tumors. DNA
methyltransferases are responsible for the maintenance
and de novo methylation of DNA. DMT1 has preferential
activity for hemi-methylated DNA and is essential for the
inheritance of methylation patterns through DNA replica-
tion. DNMT3A and DNMT3B perform the genome-wide
wave of demethylation after fertilization followed by the
establishment of a new methylation pattern during
implantation. Methylation of DNA essentially leads to a
repression of transcription by interfering with the consen-Page 4 of 6
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finger transcription factors) and through the binding of
methyl-CpG binding proteins (MBD). The latter provide
an enhanced transcriptional control. For example MBD3
is a component of the nucleosome remodeling and his-
tone deacetylation co-repressor complex (NuRD), which
can be recruited to the DNA by repressive transcription
factors. MeCP2 is the first cloned MBD and a highly abun-
dant protein that recruits transcriptional co-repressors,
interferes with chromatin-modifying enzymes and also
regulates the expression of certain genes. Its dysfunction
causes the RETT syndrome, a neurodevelopmental disor-
der affecting mainly females as an X-linked gene.
Specific transcription factors
Transcription factors (TF) can be grouped as general and
gene regulatory factors. General transcription factors are a
small group of highly abundant proteins that assemble on
the promoters of all genes transcribed by RNA polymerase
II, whereas thousands of different low abundant proteins
are gene regulatory TFs. Approximately 5–10% of human
genes encode gene regulatory proteins, where each is usu-
ally present in very small amounts in a cell, often less than
0.01% of the total protein content. The gene regulatory
proteins allow the individual genes of an organism to be
turned on or off specifically. Different selections of gene
regulatory proteins are present in different cell types and
thereby direct the patterns of gene expression that give
each cell type its unique characteristics. Each gene in a
eukaryotic cell is regulated differently from nearly every
other gene. Given the number of genes in eukaryotes and
the complexity of their regulation, it has been difficult to
formulate simple rules for gene regulation that apply in
every case.
The DNA sequences affecting the level of transcription are
commonly named cis-elements and the DNA-binding
proteins that change the level of transcription are referred
to as trans-elements. Cis-regulatory elements of transcrip-
tion can be grouped in core-promoters, distal promoters,
enhancers, locus control regions (LCR) or operators.
Core-promoters are located very closely to the transcrip-
tion start site and permit the binding of general transcrip-
tion factors. Enhancers are characteristic for eukaryotic
DNA sequences and promote, together with distal pro-
moters, the specific regulation of genes. Locus control
regions are super-enhancers that control the expression of
a family of genes. In prokaryotes operators and promoters
are the main regulatory DNA sequences bound by regula-
tory proteins and permit the transcription of one or sev-
eral genes. The majority of trans-regulators are either
transcriptional activators or repressors; however, some
regulatory proteins can function as both depending on the
context, like the presence of co-factors or DNA binding
sequences. Transcription factors are characterized by con-
served structural motifs. Activation domains are thought
to stimulate transcription by interacting with general tran-
scription factors in order to assist the formation of the
transcription complex on the promoter. DNA-binding
domains are necessary to permit specific binding of the
TFs to its target genes. A number of conserved structural
motifs have been identified that are common to many dif-
ferent TFs with quite different specificities, such as helix-
turn-helix proteins, homeodomain proteins, proteins
with zinc finger or leucine zipper motifs and helix-loop-
helix proteins. Many DNA-binding proteins function as
dimers and bind to symmetrical DNA sequences. Even
though the amino-acid conservation of particular
domains through evolution might be low, they can have a
very high degree of structural conservation, like the two
homeodomain proteins alpha2 of yeast and engrailed of
drosophila that are separated by more than a billion years
of evolution.
Transcriptional regulation is based on a modular con-
struction of cis-elements and combinatory control by
trans-elements. Multiple TFs can bind simultaneously to
the regulatory sequences and act together on the transcrip-
tion of a gene. When several transcriptional activators are
bound to the regulatory sequences upstream of the pro-
moter, the increase in transcription rate is higher than
expected from an additive effect. Thus transcriptional syn-
ergy is typically observed between different activators.
Transcriptional regulation is generally achieved by tuning
the amount or activity of TFs, by interference with the
RNA polymerase binding or initiation, or by alteration of
the chromatin structure. Enhancers are essential for the
rate of transcription that would otherwise frequently only
be at low basal levels. Enhancers are not only active when
placed just upstream of the promoter, but also when
inserted up to several kilobases either upstream or down-
stream from the transcriptional start site. They can be
active in either forward or backward orientation. Gene
repressors can function through competitive DNA bind-
ing with activators, by masking of the activation DNA sur-
face or direct interaction with general transcription
factors.
The existence of gene regulatory proteins became first evi-
dent in bacteria with the lambda repressor encoded by
bacteriophage lambda. It shuts off viral genes coding for
protein components of new virus particles and thereby
enables the viral genome to remain a silent passenger.
Generally, gene regulatory proteins bind to the major
groove of the DNA, where the pattern of attractive force
represented by the edges of each base pair show a higher
degree of diversity than at the minor groove. The surface
of such regulatory proteins is extensively complementary
to the special features of the double helix in the recog-
nized sequence. Most proteins make a large number ofPage 5 of 6
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contacts with DNA where each individual contact is weak
but all together ensure a tight interaction. The binding of
proteins to DNA is mainly driven by Van der Waals con-
tacts (69,45%) followed by hydrogen bonds (15%) and
water mediated bonds (14.5%). Hydrophobic attractions
are rarely important (0.05%). Beside base specific interac-
tions, a high number of interactions with the phosphate
and sugar residues of the DNA backbone ensure the stabi-
lization of the protein-DNA complex.
Emerging biotechnologies
Several methods are commonly used to analyze DNA-pro-
tein and protein-protein interactions, such as DNA foot-
printing, electrophoretic mobility shift assays (EMSA),
chromatin immunoprecipitation (ChIP), DNA affinity
chromatography and two-hybrid systems. Reporter gene
assays in cell culture or transgenic animals allow in-vivo
studies of transcriptional activity, time-point and loca-
tion. The treatment of genomic DNA with bisulfite, con-
verting cytosine to uracil, can be used to identify
methylated DNA sequences. Microarrays and quantitative
real-time PCR assays are frequently used to study the level
of gene expression on a genome-wide or focused scale.
Beside standard gene expression microarrays, tilling arrays
promote the discovery of new transcripts by the annota-
tion of transcriptionally active regions and together with
exon arrays, they are suitable for the quantification of
alternative splicing events. The combination of ChIP with
target detection through arrays (ChIP-on-chip) enables
the identification of regulatory elements on a global scale.
It can be used to identify in-vivo DNA and chromatin
binding sites of transcription factors, active promoters as
a measure of gene expression and to investigate histone
modifications important for chromatin structure. The first
application of ChIP-on-chip has been in yeast, and in
2004 the ENCODE consortium has been launched aiming
to identify all functional regulatory elements in human
[1]. One limitation of ChIP-on-chip is that the discovery
of TF binding sites depends on the condition under which
a TF of interest is expressed, nuclear and active. Here, dou-
ble-stranded DNA arrays (protein binding microarrays)
provide the method of choice for in-vitro binding motif
and site discovery in a high-throughput manner. Further-
more, it allows the analysis of TF affinity features in the
perspective of nucleotide variations. Protein binding
microarrays are less dependent on the availability of spe-
cific antibodies as they are mainly performed with tagged
TFs. The latter is also feasible for ChIP-on-chip, but here
the effect of over-expression needs to be considered.
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